Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-06-24
DOI
10.1093/infdis/jiaa377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
- (2019) Christine A. Bricault et al. Cell Host & Microbe
- Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
- (2019) Frances H Priddy et al. Lancet HIV
- Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
- (2019) Jeffrey Umotoy et al. IMMUNITY
- Engineered HIV antibody passes muster
- (2019) Lynn Morris Lancet HIV
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
- (2019) Martin R Gaudinski et al. Lancet HIV
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History
- (2018) Hilary D. Marston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
- (2018) Yunda Huang et al. Human Vaccines & Immunotherapeutics
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
- (2018) Martin R. Gaudinski et al. PLOS MEDICINE
- Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
- (2018) Yehuda Z. Cohen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
- (2018) Elise Landais et al. Retrovirology
- Preventive and therapeutic features of broadly neutralising monoclonal antibodies against HIV-1
- (2018) Juan P Jaworski et al. Lancet HIV
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Antibody-mediated prevention and treatment of HIV-1 infection
- (2018) Henning Gruell et al. Retrovirology
- The expanding array of HIV broadly neutralizing antibodies
- (2018) Laura E. McCoy Retrovirology
- Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline
- (2018) Erin Sparrow et al. VACCINE
- Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
- (2017) Christian Fercher et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Use of broadly neutralizing antibodies for HIV-1 prevention
- (2017) Amarendra Pegu et al. IMMUNOLOGICAL REVIEWS
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- (2017) Kenneth H. Mayer et al. PLOS MEDICINE
- Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
- (2017) Yousuf Ahmed et al. AIDS Research and Therapy
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
- (2016) Ann J Hessell et al. NATURE MEDICINE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Broadly Neutralizing Antibodies for HIV Eradication
- (2016) Kathryn E. Stephenson et al. Current HIV/AIDS Reports
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anatomical, Physiological, and Experimental Factors Affecting the Bioavailability of sc-Administered Large Biotherapeutics
- (2015) Anas M. Fathallah et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12
- (2015) Evangelia Vamvaka et al. PLANT BIOTECHNOLOGY JOURNAL
- Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
- (2015) Julian K-C. Ma et al. PLANT BIOTECHNOLOGY JOURNAL
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide
- (2014) Georgina C. Morris et al. PLoS One
- HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission
- (2014) Yegor Voronin et al. PLOS MEDICINE
- Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
- (2012) Yanan Zheng et al. mAbs
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
- (2011) R. Diskin et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started